发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 155 |
| CHINA MAINLAND | 137 |
| England | 99 |
| Japan | 94 |
| India | 49 |
| GERMANY (FED REP GER) | 43 |
| Denmark | 41 |
| Italy | 41 |
| Wales | 29 |
| Sweden | 28 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| NOVO NORDISK | 50 |
| ELI LILLY | 43 |
| SANOFI-AVENTIS | 32 |
| BHARTI HOSP | 21 |
| UNIV HOSP LLANDOUGH | 21 |
| UNIVERSITY OF LONDON | 21 |
| MERCK & COMPANY | 17 |
| BOEHRINGER INGELHEIM | 15 |
| UNIVERSITY OF LIVERPOOL | 15 |
| CHINESE ACADEMY OF MEDICAL SCIENCES - PEKING U... | 14 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Effectiveness and Safety of a Novel Care Model for the M... | 34 |
| Ertugliflozin in Patients with Stage 3 Chronic Kidney Di... | 26 |
| Ertugliflozin Compared with Glimepiride in Patients with... | 24 |
| Rates of Hypoglycemia Predicted in Patients with Type 2 ... | 20 |
| Prevalence and Risk Factors for Diabetes Mellitus in Nig... | 18 |
| Ertugliflozin and Sitagliptin Co-initiation in Patients ... | 17 |
| Diabetic Gastroparesis: Principles and Current Trends in... | 14 |
| A View Beyond HbA1c: Role of Continuous Glucose Monitori... | 13 |
| Empagliflozin Induces Transient Diuresis Without Changin... | 12 |
| SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-T... | 11 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| DIABETES THER | 175 |
| DIABETES OBES METAB | 84 |
| DIABETES RES CLIN PR | 33 |
| ADV THER | 26 |
| DIABETES TECHNOL THE | 24 |
| J DIABETES INVEST | 22 |
| ACTA DIABETOL | 21 |
| DIABETES CARE | 19 |
| INT J ENV RES PUB HE | 17 |
| BMJ OPEN DIAB RES CA | 16 |